Viracta Therapeutics (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- April 04, 2017
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $18,400,000
Company Info
- Founders
- Ivor Royston, M. D.
- Company Description
- Viracta Therapeutics is a precision oncology company focused on new treatment of virus-associated malignancies.
- Market
- Viral-associated cancers and other serious diseases
- Location
- San Diego, California, USA
- Coinvestors
- Forward Ventures, Latterell Venture Partners, NantKwest, Wicklow Capital